Last reviewed · How we verify
NCT04988503
Bare Platinum Coils Versus Second-generation Hydrocoils
NA trial testing Coil embolization in Aneurysm, Ruptured in 68 participants. Terminated before completion.
28 February 2025
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 68 |
| Start date | 30 August 2021 |
| Primary completion | 28 February 2025 |
| Estimated completion | 28 February 2025 |
| Sites | 3 locations across South Korea |
Drugs / interventions tested
- Coil embolization
Conditions studied
- Aneurysm, Ruptured — all drugs for Aneurysm, Ruptured →
- Intracranial Aneurysm — all drugs for Intracranial Aneurysm →
Sponsor
Seoul National University Hospital
Who can join
19 and older, any sex, with Aneurysm, Ruptured or Intracranial Aneurysm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparison of clinical and radiological outcomes between bare platinum coil group and second-generation hydrogel coils for treatment of ruptured intracranial aneurysms.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Hydrogels in the clinic: An update.
Clegg JR, Adebowale K, Zhao Z, Mitragotri S. · · 2024 · cited 64× · PMID 39545079 · DOI 10.1002/btm2.10680 -
Comparison of second-generation hydrogel embolic coils and bare platinum coils in ruptured intracranial aneurysm treatment: A prospective, multicenter, randomized controlled study.
Ban SP, Kwon OK, Kim YD, Shim HS, et al · · 2026 · PMID 41844924 · DOI 10.1007/s10143-026-04212-1
Verify or expand the search:
- PubMed search for NCT04988503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aneurysm, Ruptured
Currently open trials in the same condition.
- NCT07050381 — The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM · recruiting
- NCT06866210 — Risk Analysis of Intracranial Aneurysm Rupture Through Social Determinants of Health · active not recruiting
- NCT05880680 — SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry · recruiting
- NCT04876638 — Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH) · Phase 2 · active not recruiting
- NCT03214601 — Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System · NA · active not recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04988503 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 25 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04988503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing